Ajax-Loading

AstraZeneca PLC - Total Stockholder Equity

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Stockholder-Equity" stands at 45.97 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of AstraZeneca PLC's third quarter, the item "Total Stockholder Equity" stands at 45.97 Billion USD. This represents an increase of 2.59 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.66 percent compared to the value the year prior.
The 1 year change in percent is 12.66.
The 3 year change in percent is 30.77.
The 5 year change in percent is 237.58.
The 10 year change in percent is 164.69.

The Serie's long term average value is 24.03 Billion United States Dollars. It's latest available value, on 09/30/2025, is 91.30 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is +282.17%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Total Stockholder Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Stockholder Equity905,699,262,464.00
LogoJohnson & Johnson - Total Stockholder Equity486,508,953,600.00
LogoAbbVie Inc - Total Stockholder Equity399,570,305,024.00
LogoRoche Holding AG - Total Stockholder Equity317,433,206,677.55
LogoNovartis AG - Total Stockholder Equity255,096,620,580.91